# BGLC (BioNexus Gene Lab Corp.) - SEC EDGAR Financial Statements

> BioNexus Gene Lab Corp. reported $631K in revenue and a net loss of $2.92M for the trailing twelve months ended September 30, 2026 (down 98.1% year over year), with a 2.0% gross margin and a -459.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/BGLC
- Markdown: https://convexityos.com/fundamentals/BGLC.md
- SEC CIK: 0001737523
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001737523&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $631K | -98.1% YoY |
| Operating Income | TTM | -$2.90M | -459.6% margin |
| Net Income | TTM | -$2.92M | -463.1% net margin |
| Diluted EPS | TTM | -$1.08 | Split-adjusted |
| Free Cash Flow | TTM | $129K | 20.5% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $866K | Total debt: $185K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $7.42M | $9.51M | $9.77M | $10.93M | $13.36M | $11.39M | $127K | $212K |
| Cost of Revenue | $6.34M | $8.22M | $8.44M | $9.67M | $11.10M | $9.67M | $71K | -$184K |
| **Gross Profit** | $1.09M | $1.29M | $1.33M | $1.26M | $2.27M | $1.72M | $56K | $29K |
| Research & Development | $51K | $48K | $55K | -- | -- | -- | -- | -- |
| Selling, General & Admin | $3.27M | $3.86M | $3.04M | -- | -- | -- | -- | -- |
| Total Operating Expenses | $4.48M | $4.94M | -$4.41M | -- | -- | -- | -- | -- |
| **Operating Income** | -$2.97M | -$1.57M | -$2.59M | -$291K | $1.06M | $1.27M | -$276K | $60K |
| **EBITDA** | -$2.85M | -$1.45M | -$2.51M | -$200K | $1.15M | $1.36M | -$234K | $101K |
| Interest Income | $84K | $148K | $69K | -- | -- | -$6.3K | -- | -- |
| Interest Expense | -- | -- | $14K | $12K | -- | -- | -- | -- |
| Income Before Tax | -$2.98M | -$1.59M | -$2.61M | -$304K | $1.04M | -- | -- | -- |
| Income Tax Expense | $0 | -$3.5K | -$22K | -$52K | -$291K | -- | $25K | -$33K |
| **Net Income** | -$2.98M | -$1.60M | -$2.63M | -$356K | $752K | $1.09M | -$246K | $26K |
| Basic EPS | -- | -- | -- | -- | -- | $0.12 | $0.00 | $0.00 |
| **Diluted EPS** | -- | -$0.90 | -$1.66 | -- | -- | $0.12 | $0.00 | $0.00 |
| Basic Shares Outstanding | -- | -- | -- | -- | -- | 10.3M | 8.6M | 6.6M |
| Diluted Shares Outstanding | -- | 1.8M | 1.6M | -- | -- | 10.3M | 8.6M | 6.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $48K | $76K | $23K | $484K | $2.54M | $2.26M | $2.14M | $2.52M |
| Cost of Revenue | $43K | $63K | $24K | $488K | $2.17M | $1.89M | $1.79M | $2.21M |
| **Gross Profit** | $4.5K | $13K | -$790 | -$4.0K | $378K | $368K | $343K | $309K |
| Research & Development | $14K | $14K | $14K | $11K | $15K | $13K | $12K | $17K |
| Selling, General & Admin | $346K | $335K | $380K | $207K | $1.00M | $1.13M | $933K | $661K |
| Total Operating Expenses | $1.08M | $416K | $597K | $1.14M | $1.19M | $1.19M | $1.05M | $1.40M |
| **Operating Income** | -$1.05M | -$282K | -$540K | -$1.02M | -$706K | -$611K | -$618K | -$416K |
| **EBITDA** | -$1.02M | -$254K | -$512K | -$995K | -$677K | -$583K | -$592K | -$387K |
| Interest Income | $17K | $21K | $17K | $9.8K | $21K | $30K | $24K | $34K |
| Income Before Tax | -$1.05M | -$286K | -$544K | -$1.04M | -$709K | -$616K | -$623K | -$422K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$81K |
| **Net Income** | -$1.05M | -$286K | -$544K | -$1.04M | -$709K | -$616K | -$623K | -$348K |
| **Diluted EPS** | -$0.39 | -$0.12 | -$0.23 | -- | -$0.40 | -$0.34 | -$0.35 | -- |
| Diluted Shares Outstanding | 2.7M | 2.4M | 2.4M | -- | 1.8M | 1.8M | 1.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.38M | $2.89M | $2.62M | $612K | $2.12M | $2.79M | $859K | $1.26M |
| **Cash & Short-Term Investments** | $2.38M | $2.89M | $2.62M | $612K | $2.12M | $2.79M | $859K | $1.26M |
| Accounts Receivable, Net | $506K | $1.38M | $800K | $2.87M | $3.36M | -- | -- | -- |
| Inventory | $677K | $1.39M | $1.14M | $978K | $1.52M | $1.18M | $7.6K | $15K |
| Other Current Assets | $83K | $0 | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $5.37M | $7.43M | $8.05M | $6.02M | $7.15M | $7.99M | $883K | $1.30M |
| Property, Plant & Equipment, Net | $1.60M | $1.52M | $1.51M | $1.51M | $1.63M | $1.79M | $313K | $342K |
| Other Non-Current Assets | $83K | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $3.89M | $3.00M | $3.35M | $2.72M | $2.42M | $2.13M | $349K | $354K |
| **Total Assets** | $9.25M | $10.43M | $11.40M | $8.74M | $9.57M | $10.12M | $1.23M | $1.65M |
| Accounts Payable | $2.3K | $1.50M | $1.40M | $1.86M | $2.01M | $3.17M | $0 | -- |
| **Total Current Liabilities** | $521K | $1.95M | $1.63M | $2.00M | $2.33M | $3.37M | $52K | $63K |
| **Total Non-Current Liabilities** | $117K | $160K | $111K | $71K | $66K | $80K | $57K | $67K |
| **Total Liabilities** | $638K | $2.11M | $1.74M | $2.08M | $2.39M | $3.45M | $109K | $130K |
| **Total Debt (incl. Leases)** | $176K | $211K | $133K | $57K | $77K | $123K | $89K | $82K |
| Common Stock | $20.17M | $17.33M | $17.19M | $10.93M | $10.78M | $10.78M | $6.48M | $6.65M |
| Retained Earnings | -$6.43M | -$3.44M | -$1.84M | $1.16M | $1.51M | $761K | -$333K | -$87K |
| Accumulated Other Comp. Income | -$121K | -$555K | -$677K | -$409K | -$100K | $134K | -$17K | -$27K |
| **Total Stockholders' Equity** | $8.61M | $8.32M | $9.66M | $6.67M | $7.18M | $6.66M | $1.12M | $1.52M |
| Total Equity | $8.61M | $8.32M | $9.66M | $6.67M | $7.18M | $6.66M | $1.12M | $1.52M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $866K | $1.23M | -- | $2.38M | -- | -- | -- | $2.89M |
| **Cash & Short-Term Investments** | $866K | $1.23M | -- | $2.38M | -- | -- | -- | $2.89M |
| Accounts Receivable, Net | $38K | $16K | $80K | $506K | $1.52M | $1.85M | $1.44M | $1.38M |
| Inventory | $636K | $653K | $667K | $677K | $1.01M | $1.22M | $1.18M | $1.39M |
| Other Current Assets | -- | $583K | $333K | $83K | -- | -- | -- | $0 |
| **Total Current Assets** | $4.19M | $4.94M | $5.20M | $5.37M | $5.63M | $6.38M | $6.54M | $7.43M |
| Property, Plant & Equipment, Net | $1.51M | $1.54M | $1.58M | $1.60M | $1.57M | $1.59M | $1.52M | $1.52M |
| Other Non-Current Assets | $833K | -- | -- | $83K | -- | -- | -- | -- |
| **Total Non-Current Assets** | $4.57M | $3.78M | $3.84M | $3.89M | $1.99M | $3.04M | $2.94M | $3.00M |
| **Total Assets** | $8.76M | $8.73M | $9.04M | $9.25M | $7.62M | $9.42M | $9.48M | $10.43M |
| Accounts Payable | $13K | $7.9K | $2.1K | $2.3K | $185K | $1.37M | $1.18M | $1.50M |
| **Total Current Liabilities** | $1.12M | $813K | $796K | $521K | $678K | $1.76M | $1.56M | $1.95M |
| Long-Term Debt | $54K | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $119K | $135K | $150K | $117K | $127K | $141K | $148K | $160K |
| **Total Liabilities** | $1.24M | $948K | $947K | $638K | $805K | $1.90M | $1.71M | $2.11M |
| **Total Debt (incl. Leases)** | $185K | $199K | $216K | $176K | $184K | $197K | $200K | $211K |
| Common Stock | $20.97M | $20.17M | $20.17M | $20.17M | $17.33M | $17.33M | $17.33M | $17.33M |
| Retained Earnings | -$8.31M | -$7.26M | -$6.97M | -$6.43M | -$5.39M | -$4.68M | -$4.07M | -$3.44M |
| Accumulated Other Comp. Income | -$130K | -$127K | -$99K | -$121K | -$113K | -$116K | -$483K | -$555K |
| **Total Stockholders' Equity** | $7.52M | $7.78M | $8.09M | $8.61M | $6.82M | $7.52M | $7.77M | $8.32M |
| Total Equity | $7.52M | $7.78M | $8.09M | $8.61M | $6.82M | $7.52M | $7.77M | $8.32M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.98M | -$1.60M | $2.63M | -$356K | $752K | $1.09M | -$246K | $26K |
| Depreciation & Amortization | $112K | $125K | $83K | $91K | $91K | $91K | $42K | $41K |
| Stock-Based Compensation | $795K | $141K | -- | -- | -- | -- | -- | -- |
| Change in Inventory | $712K | -$251K | $160K | -$544K | $346K | -$147K | -$7.7K | -$17K |
| **Operating Cash Flow** | -$1.84M | -$2.09M | -$1.82M | $552K | $9.2K | $553K | -$217K | -$274K |
| Capital Expenditure | -$37K | -$227K | -$149K | $0 | -$3.2K | -$422K | -$13K | $40K |
| **Free Cash Flow** | -$1.88M | -$2.32M | -$1.97M | $552K | $6.0K | $131K | -$230K | -$234K |
| **Investing Cash Flow** | $945K | $418K | -$1.79M | -$450K | -$491K | $1.32M | -$13K | -$52K |
| Common Stock Issued | $267K | -- | -- | -- | -- | -- | -$163K | $742K |
| **Financing Cash Flow** | $299K | $4.0K | $6.27M | $108K | -$28K | -$4.9K | -$181K | $743K |
| **Net Change in Cash** | -$401K | -$1.63M | $2.40M | -$5.1K | -$664K | -- | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.05M | -$286K | -$544K | -$1.04M | -$709K | -$616K | -$623K | -$2.85M |
| Depreciation & Amortization | $28K | $28K | $28K | $28K | $29K | $28K | $27K | $30K |
| Stock-Based Compensation | $800K | -- | -- | -- | $0 | -- | -- | -- |
| Change in Inventory | -- | -- | $9.5K | $331K | $208K | -$36K | $209K | $452 |
| **Operating Cash Flow** | -$257K | -$422K | -$148K | $961K | -$1.24M | -$738K | -$824K | $219K |
| Capital Expenditure | -$2.5K | -$250 | -$325 | -$977 | -$5.5K | -$21K | -$9.1K | -$4.0K |
| **Free Cash Flow** | -$260K | -$423K | -$148K | $960K | -$1.24M | -$759K | -$833K | $215K |
| **Investing Cash Flow** | -$13K | $416K | -$14K | -$5.7K | $995K | -$29K | -$16K | $554K |
| **Financing Cash Flow** | $104K | $14K | $60K | $267K | $34K | -$1.0K | -$860 | -$142K |
| **Net Change in Cash** | -$168K | -$6.0K | -$88K | $1.13M | -$180K | -$552K | -$798K | $222K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 14.6% | 13.6% | 13.6% | 11.5% | 17.0% | 15.1% | 44.0% | 13.5% |
| **Operating Margin** | -39.9% | -16.5% | -26.5% | -2.7% | 7.9% | 11.2% | -217.2% | 28.2% |
| **Net Profit Margin** | -40.2% | -16.8% | -26.9% | -3.3% | 5.6% | 9.6% | -194.1% | 12.5% |
| Return on Equity (ROE) | -34.6% | -19.2% | -27.2% | -5.3% | 10.5% | 16.4% | -22.0% | 1.7% |
| Return on Assets (ROA) | -32.3% | -15.3% | -23.1% | -4.1% | 7.8% | 10.8% | -20.0% | 1.6% |
| Current Ratio | 10.30x | 3.81x | 4.93x | 3.00x | 3.07x | 2.37x | 17.11x | 20.64x |
| Quick Ratio | 9.00x | 3.10x | 4.24x | 2.52x | 2.42x | 2.02x | 16.97x | 20.40x |
| Debt to Equity | 0.02x | 0.03x | 0.01x | 0.01x | 0.01x | 0.02x | 0.08x | 0.05x |
| **Revenue Growth (YoY)** | -21.9% | -2.7% | -10.6% | -18.2% | +17.3% | +8872.0% | -40.2% | -- |
| Gross Profit Growth (YoY) | -15.8% | -3.0% | +5.6% | -44.5% | +31.8% | +2977.3% | +94.3% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -127.6% | -17.1% | -- | -560.3% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -147.4% | -31.3% | -- | -1031.7% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -430.2% | +5923.6% | -98.3% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -457.3% | +9098.6% | -95.4% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 2.0% | 12.3% | 14.0% | 14.6% | 14.8% | 14.1% | 13.7% | 13.6% |
| **Operating Margin** | -459.6% | -81.6% | -54.2% | -39.8% | -24.8% | -31.2% | -22.8% | -16.5% |
| **Net Profit Margin** | -463.1% | -82.4% | -54.7% | -40.2% | -24.3% | -30.7% | -22.9% | -16.8% |
| Return on Equity (ROE) | -38.8% | -33.1% | -35.9% | -34.6% | -33.7% | -39.0% | -27.3% | -19.2% |
| Return on Assets (ROA) | -33.3% | -29.5% | -32.1% | -32.3% | -30.1% | -31.1% | -22.3% | -15.3% |
| Current Ratio | 3.74x | 6.08x | 6.52x | 10.30x | 8.30x | 3.63x | 4.19x | 3.81x |
| Quick Ratio | 3.17x | 5.28x | 5.69x | 9.00x | 6.81x | 2.94x | 3.44x | 3.10x |
| Debt to Equity | 0.02x | 0.03x | 0.03x | 0.02x | 0.03x | 0.03x | 0.03x | 0.03x |
| **Revenue Growth (YoY)** | -98.1% | -96.6% | -98.9% | -80.8% | -3.3% | +14.5% | -10.3% | +11.0% |
| Gross Profit Growth (YoY) | -98.8% | -96.5% | -100.2% | -101.3% | +15.7% | +27.5% | -5.9% | +16.0% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -335.9% | -- | -261.5% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -409.5% | -- | -212.9% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | +338.4% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | +346.2% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
